Fundraising Fox
Jnana Therapeutics
acquired by OtsukaAustin, US · Founded 2016 · 7 known investors
Find your way into Jnana Therapeutics
Sign up to see every warm intro you have to Jnana Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Jnana Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Jnana has developed RAPID, a next-generation chemoproteomics platform that enables rapid discovery of small molecule drugs targeting previously inaccessible disease targets by identifying novel binding sites on complex proteins. The platform uses proprietary reactive affinity probes and high-throughput screening to accelerate drug discovery across challenging target classes including transporters, transcription factors, and GPCRs.
Founders & leadership
Jnana Therapeutics was founded in 2016 by Joanne Dove Kotz.
Investors · 7
How we know: Avalon BioVentures's portfolio page · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Bain Capital Life Sciences's portfolio page · jnanatx.com · Not right? Tell us
How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us
How we know: RA Capital's portfolio page · jnanatx.com · Not right? Tell us
How we know: jnanatx.com · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · jnanatx.com · Not right? Tell us
Funding
SEC filings, press & company announcements$157M disclosed across 2 of 3 rounds · 2021–2022
- Undisclosed amountSeries CNov 2022
Bain Capital Life Sciences (lead), Avalon Ventures, Pfizer Ventures, Polaris Partners, RA Capital Management, Versant Ventures
Source ↗
▶$107MraisedJan 2024 · 8 investors · BiotechnologyRule 506(b)
- Annie C. ChenDirector
- Douglas W. PaganExecutive Officer
- Ronald Renaud, Jr.Director
- George VratsanosExecutive Officer
- Carlo RizzutoDirector
- Terrance G. McGuireDirector
- Joanne D. KotzExecutive Officer, Director
- Donald W. NicholsonDirector
- Caroline Stark BeerExecutive Officer
- Matthew HammondDirector
- Brian M. CaliDirector
- Offering amount
- $107M
- Amount sold
- $107M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50MraisedAug 2021 · 14 investors · BiotechnologyRule 506(b)
- Joel BarrishExecutive Officer
- Donald W. NicholsonDirector
- Matthew HammondDirector
- Caroline Stark BeerExecutive Officer
- Carlo RizzutoDirector
- Annie C. ChenDirector
- Brian M. CaliDirector
- Terrance G. McGuireDirector
- Stuart SchreiberDirector
- Joanne D. KotzExecutive Officer, Director
- Kevin J. KinsellaDirector
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Jnana Therapeutics do?
- Jnana has developed RAPID, a next-generation chemoproteomics platform that enables rapid discovery of small molecule drugs targeting previously inaccessible disease targets by identifying novel binding sites on complex proteins. The platform uses proprietary reactive affinity probes and high-throughput screening to accelerate drug discovery across challenging target classes including transporters, transcription factors, and GPCRs.
- Who founded Jnana Therapeutics?
- Jnana Therapeutics was founded by Joanne Dove Kotz in 2016.
- Who are Jnana Therapeutics's investors?
- Jnana Therapeutics's investors include Avalon BioVentures, Bain Capital Life Sciences, Pfizer Venture Investments, RA Capital, Pfizer Ventures, Polaris Partners, Versant Ventures.
- How much funding has Jnana Therapeutics raised?
- Jnana Therapeutics has disclosed $157M raised across 2 of its 3 known rounds.
- Who acquired Jnana Therapeutics?
- Jnana Therapeutics was acquired by Otsuka.
- Where is Jnana Therapeutics headquartered?
- Jnana Therapeutics is headquartered in Austin, US.